Approval · Notice of Compliance 32641 · 2024
JAMP LOPERAMIDE: Notice of Compliance 32641
Issued February 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32641
- Date
- February 5, 2024
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- IMODIUM LIQUI-GELS (McNeil Consumer Healthcare, division of Johnson & Johnson Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP LOPERAMIDE | 02544989 | Marketed |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per CAP